Daewoong’s botulinum toxin Nabota debuts in Saudi Arabia
South Korea's leading drugmaker Daewoong Pharmaceutical announced on Friday that it has officially launched its botulinum toxin product Nabota in Saudi Arabia, the largest market for the neurotoxin medication in the Middle East. The launch comes after …